Study Explores Comfort With Non In-Person Test Results

This article originally appeared here.
Share this content:
Study Explores Comfort With Non In-Person Test Results
Study Explores Comfort With Non In-Person Test Results

MONDAY, Nov. 9, 2015 (HealthDay News) -- Patients have different preferences for non in-person receipt of test results, with preferences varying by test, according to a study published in the November-December issue of the Journal of the American Board of Family Medicine.

Jeannine R. LaRocque, Ph.D., from the Georgetown University Medical Center in Washington, D.C., and colleagues conducted a cross-sectional survey involving 409 participants to examine preferences for modes of non in-person communication for medical test results.

The researchers found that ≥50 percent of participants reported that they were comfortable receiving results for a blood cholesterol test or colonoscopy in four of the seven non in-person communication methods (password-protected website, personal voicemail, personal e-mail, and letter preferred over home voicemail, fax, and mobile phone text). For non-HIV sexually transmitted infections (STIs), >50 percent reported that they were comfortable with only one non in-person communication method (password-protected websites), and no method was preferred for genetic tests. Regardless of test type, patients were least comfortable with receiving information by fax. For personal voicemail, personal e-mail, mobile phone text, and password-protected websites, statistical differences were seen among comfort levels of blood cholesterol and colonoscopy tests and both STIs and genetic testing; no differences were seen between STIs and genetic testing. Familiarity with test was not associated with comfort of receiving information.

"Participants demonstrated preferences in how they received test results by non in-person communication methods, preferring personal e-mail and password-protected websites, but did not prefer fax," the authors write. "Importantly, participants also demonstrated that preference was dependent upon test type."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »